Swissray to sell Imation printers

Article

Imation of Oakdale, MN, gained an additional distribution channel for its DryView line of dry laser printers through an agreement with the Swissray Information Solutions division of Swissray International. New York City-based Swissray has rights for one

Imation of Oakdale, MN, gained an additional distribution channel for its DryView line of dry laser printers through an agreement with the Swissray Information Solutions division of Swissray International. New York City-based Swissray has rights for one year to the Imation printers, which Swissray hopes will be a good complement to the company's digital x-ray systems.

In other Swissray news, the company this month reported that it sold two AddOn-Multi-System digital x-ray devices to the University of Texas Medical Branch at Galveston. On the financial side, Swissray stockholders on Oct. 1 approved a one-for-10 reverse stock split designed to bring the company into compliance with NASDAQ listing requirements. Swissray shares were trading at 19 a share at the time of the vote.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.